| scholarly article | Q13442814 |
| P50 | author | Osamu Abe | Q88616956 |
| P2093 | author name string | Toshikazu Imae | |
| Akihiro Haga | |||
| Hideomi Yamashita | |||
| Keiichi Nakagawa | |||
| Kanabu Nawa | |||
| Wataru Takahashi | |||
| Takeshi Ota | |||
| Sho Ozaki | |||
| Shuri Aoki | |||
| P2860 | cites work | The oligometastatic state - separating truth from wishful thinking | Q46288612 |
| Stereotactic body radiotherapy: A survey of contemporary practice in six selected European countries | Q46512504 | ||
| A metal-based inhibitor of tumor necrosis factor-α. | Q50243911 | ||
| Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". | Q51100099 | ||
| Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. | Q53496956 | ||
| The Quality of Toxicity Reporting and the Story of the Lung SBRT "No-Fly Zone". | Q54247791 | ||
| Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer | Q59587430 | ||
| Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer | Q59587541 | ||
| Curative radiotherapy for a second primary lung cancer arising after pneumonectomy — techniques and results | Q59587676 | ||
| Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma | Q73068985 | ||
| Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy | Q74464146 | ||
| Evaluation of T factor, surgical method, and prognostic factors in central type lung cancer | Q78505964 | ||
| Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study | Q80587769 | ||
| Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy | Q83575603 | ||
| Stereotactic body radiotherapy for lung tumors at the pulmonary hilum | Q84146368 | ||
| Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure | Q84493344 | ||
| The Quality of Toxicity Reporting and the Story of the Lung SBRT "No-Fly Zone". In Regard to Oskan | Q86455855 | ||
| Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications | Q87536544 | ||
| Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors | Q24614112 | ||
| Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors | Q30505678 | ||
| Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials | Q30656342 | ||
| No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236 | Q33758565 | ||
| Stereotactic body radiation therapy for inoperable early stage lung cancer | Q34010065 | ||
| Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review | Q34312788 | ||
| Stereotactic body radiotherapy for oligometastases. | Q34320125 | ||
| Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer | Q34575077 | ||
| Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy | Q34771688 | ||
| Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer | Q36241457 | ||
| Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes. | Q36753846 | ||
| G-quadruplexes for luminescent sensing and logic gates | Q36783571 | ||
| Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant. | Q37607498 | ||
| Oligometastases and oligo-recurrence: the new era of cancer therapy | Q37667254 | ||
| Novel insights of oligometastases and oligo-recurrence and review of the literature | Q38042427 | ||
| Bioactive luminescent transition-metal complexes for biomedical applications | Q38114391 | ||
| The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far? | Q38225135 | ||
| Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity | Q38228512 | ||
| Radiation pneumonitis after stereotactic radiation therapy for lung cancer | Q38256158 | ||
| Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned | Q38290655 | ||
| SBRT for centrally localized NSCLC - What is too central? | Q39135612 | ||
| Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial | Q39847699 | ||
| The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy | Q41757810 | ||
| Stereotactic body radiotherapy for small lung tumors in the University of Tokyo Hospital | Q42033188 | ||
| 4D registration and 4D verification of lung tumor position for stereotactic volumetric modulated arc therapy using respiratory-correlated cone-beam CT. | Q42476141 | ||
| Impact of flattening-filter-free techniques on delivery time for lung stereotactic volumetric modulated arc therapy and image quality of concurrent kilovoltage cone-beam computed tomography: a preliminary phantom study. | Q42751946 | ||
| Preoperative chemotherapy for lung cancer does not increase surgical morbidity | Q43579076 | ||
| Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. | Q44017103 | ||
| Stereotactic body radiotherapy for central lung tumors | Q44330893 | ||
| Combination of i-motif and G-quadruplex structures within the same strand: formation and application. | Q44496020 | ||
| Patterns-of-care for thoracic stereotactic body radiotherapy among practicing radiation oncologists in the United States | Q46120072 | ||
| Potential for Interfraction Motion to Increase Esophageal Toxicity in Lung SBRT. | Q46139466 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 4498-4506 | |
| P577 | publication date | 2018-07-23 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study | |
| P478 | volume | 16 |
| Q90697953 | Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients |
| Q90017826 | Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes |
Search more.